15Jul 2023
A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma: end points, censoring and equipoise

A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma: end points, censoring and equipoise

In the latest ATLAS trial, a comprehensive comparison of maintenance strategies post-hematopoietic stem cell transplantation for multiple myeloma sheds light on critical appraisal themes. The report delves into crucial aspects like endpoints, trial design's equipoise, and the significance of censoring in ensuring result validity. This study presents an opportunity to examine these vital factors and their impact on the overall understanding of multiple myeloma treatment.

  • #oncology

Like

Save

Share